Legal Terms & Patents

Skip to main content
NeuroPace, Inc.
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
  • Resources
    • Find a Center
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Contact Us
  • Blog
  • Active Clinical Trials
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
  • Resources
    • Find a Center
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Contact Us
  • Blog
  • Active Clinical Trials
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search

Legal Terms & Patents

Legal Terms

Copyright © 2020 NeuroPace, Inc. All Rights Reserved.

The above copyright notice applies to this page, each page of the website, the website as a whole, the arrangement and visual presentation of the pages in this website, and all contents of this website, including HTML code, graphics, images, and any other material. You may view, download, or print the materials on the website for your personal non-commercial use, provided any copyright and other legal notices remain on the pages you view, download, or print. You recognize that information presented on the website may be protected by patents, trademarks, or other proprietary rights in addition to copyright.

These Legal Terms apply to all visitors to the publicly available portion of the NeuroPace, Inc. website (the “website”). Other terms may apply to password-protected portions of the website; access to such password-protected portions is forbidden without the express consent of NeuroPace. These Legal Terms were last updated on January 2, 2020. NeuroPace reserves the right to update these Legal Terms by posting a revised version on the website, effective when posted. By using the website you accept these Legal Terms.

The materials on this website are informational only and are not intended as medical advice or a substitute for medical advice. Consult your physician for any specific medical issues or questions you may have.

The information on this website is intended for residents of the Unites States of America. Users outside of the United States access the website and use the information presented therein at their own risk. All users agree to comply with all applicable national and local laws and rules when accessing the website, for both the United States and the country from which the access is being made.

NeuroPace does not warrant the accuracy, reliability, completeness, or timeliness of the materials provided on this website. NeuroPace makes no representations or warranties that use of this website will be uninterrupted or error-free. You alone are responsible for ensuring that any data you may obtain from this website is free of viruses and any other potentially destructive material.

NeuroPace may provide links to third party websites as a convenience to the users of this website. NeuroPace does not endorse, warrant, or verify the accuracy, reliability, completeness, or timeliness of such third party websites and is not responsible for their content.

ALL MATERIALS ON THIS WEB SITE ARE PROVIDED TO YOU ON AN “AS IS,” “AS AVAILABLE” BASIS. NEUROPACE HEREBY DISCLAIMS ALL WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT.

NEUROPACE SHALL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA OR OTHER INTANGIBLE LOSSES (EVEN IF NEUROPACE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES), RESULTING FROM YOUR USE OF (OR INABILITY TO USE) THIS WEB SITE, ANY INFORMATION TRANSMITTED TO OR RECEIVED FROM THE WEB SITE, OR ANY OTHER MATTER RELATING TO THIS WEB SITE.

Patents

This virtual patent marking registry is made available to provide constructive notice of the patent rights of NeuroPace, Inc. with respect to the company’s RNS® System and its components. It is intended to serve as notice under 35 U.S.C. § 287(a). This registry may not be all inclusive, but NeuroPace endeavors to keep it up to date and accurate. Each list of patents by product applies to the product as may be sold individually or as part of a combination product or kit. If you have any questions about this list, please contact NeuroPace at 650-237-2700 and ask for the legal department.

NeuroPace® RNS® Neurostimulator
The RNS® Neurostimulator is covered by one or more of the following United States patents:, , 6,810,285, 7,787,945, 7,813,793, 7,966,073, 8,140,151, 9,101,771, 9,421,380, 9,597,032, 10,279,187, and 10,321,866. Other patents are or may be pending.

NeuroPace® Depth Lead
The Depth Lead is covered by one or more of the following United States patents: 6,810,285, 7,146,222, 7,672,736, and 8,694,130. Other patents are or may be pending.

NeuroPace® Cortical Strip Lead
The Cortical Strip Lead is covered by one or more of the following United States patents: 6,810,285, 7,146,222, 7,672,736, and 8,694,130. Other patents are or may be pending.

NeuroPace® Patient Data Management System (PDMS)
The Patient Data Management System (PDMS) is covered by one or more of the following United States patents: 9,392,972, 9,743,886, 9,955,921, 10,123,715, 10,299,728, and 10,722,176. Other patents are or may be pending.

NeuroPace® Programmer
The Programmer is covered by one or more of the following United States patents: 9,743,886, 9,955,921, 10,123,715, 10,299,728, and 10,722,176. Other patents are or may be pending.

Burr Hole Cover
The Burr Hole Cover is covered by the following United States patent: 10,517,732.

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

ABOUT US

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure
  • PATIENTS

    Safety
  • PROVIDERS

    Legal
  • INVESTORS

    Privacy Policy
  • ABOUT US

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc..

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.
  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz